The UK is witnessing a growing surge in interest surrounding mind-altering substances. Beyond the well-established use of psilocybin and LSD, researchers and adventurers are increasingly focused on less-charted areas, particularly copyright and the nascent cannabinoid, CBG. This burgeoning movement encompasses therapeutic research into emotional he